According to Dilip Bhat, Joint MD of Prabhudas Lilladher, Ranbaxy still looks reasonably available at the current levels. It is a good investment bet, he adds.
first published: Oct 11, 2013 02:27 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty slips below 25,200, LG Electronics shares down after blockbuster debut | Closing Bell
Why markets haven’t delivered and why they will turn now
Nifty Upmove Hinges On Quarterly Earnings; Will LG Electronics See A Listing Pop?|Opening Bell Live
Live: Nifty snaps 2-day winning streak but rebounds from day's low | Closing Bell | 4K
